fluorodeoxyglucose f18 has been researched along with Nevoxanthoendothelioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, MF; Mavi, ME; Salanci, BV; Turan, BS | 1 |
| Wen, Z; Zhuang, H | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Nevoxanthoendothelioma
| Article | Year |
|---|---|
Role of FDG PET/CT in the Evaluation of Therapy Response in Systemic Juvenile Xanthogranuloma.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Histiocytosis, Non-Langerhans-Cell; Humans; Positron Emission Tomography Computed Tomography; Skin; Xanthogranuloma, Juvenile | 2022 |
Therapy Response in a Pediatric Patient With Extracutaneous Juvenile Xanthogranuloma Monitored by FDG PET/CT.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Treatment Outcome; Xanthogranuloma, Juvenile | 2020 |